Barclays’s Akso Health Group AHG Stock Holding History

Barclays’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	–	–	6905
2019 Q1	$0	Sell	2 -331	-99%	-$2.87K	﹤0.01%	6973
2018 Q4	$3K	Buy	+333	New	+$5.48K	﹤0.01%	6583

Other funds holding AHG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Barclays's AHG Position: Q2 2019 in Review

Barclays sold out of Akso Health Group (AHG) in Q2 2019, closing a stake of 2 shares.

Barclays first reported a position in AHG in Q4 2018 and held it in 2 quarters. The position peaked at $3K in Q4 2018. 12 funds tracked by Wall St. Rank hold AHG as of Q2 2019.

Barclays reported no remaining Akso Health Group position as of Q2 2019 after selling out during the quarter.
Barclays sold 2 Akso Health Group shares in Q2 2019.
Barclays first reported a position in Akso Health Group in Q4 2018 and held it in 2 quarters.
Barclays's Akso Health Group position peaked at $3K in Q4 2018.
12 funds tracked by Wall St. Rank held Akso Health Group as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.